Word: dr
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
Psychologists say upwardly mobile Americans who turn to crack share personality traits that may make them vulnerable to the drug's siren call. Dr. Jeffrey Rosecan, director of the Cocaine Abuse Treatment Program at Manhattan's Columbia-Presbyterian Medical Center, sketches a profile of the typical crack user: a man in his 30s or 40s, single or divorced, with a high- pressure job, little inner peace and a history of moderate drug use and heavy drinking. "They're extremists, hard drivers, workaholics," says Rosecan. "With an all-or-nothing personality and a history of drug experimentation...
...looking like points of a sundial, would be the words -- the names and the events -- that would tell the history of the civil rights era. They begin with 17 MAY 1954 SUPREME COURT OUTLAWS SCHOOL SEGREGATION IN BROWN VS. BOARD OF EDUCATION and end with 4 APR 1968 DR. MARTIN LUTHER KING JR. ASSASSINATED MEMPHIS, TN (there will be 53 entries in all, with a conspicuous space before Brown and after King, suggesting the struggle didn't begin with the Brown decision or end with King's death). Anyone, she said -- be it someone who had lived through the events...
...Dr. James A. Talcott, an instructor at Harvard Medical School, studied thirty-three individuals who worked in a factory making cigarette filters with crocidolite fibers in 1953. Twenty-eight of the workers had died, three times the expected death rate...
First, there are those who argue that psychiatry itself is an illegitimate discipline. Dr. Thomas Szasz, for example, wrote in his book The Myth of Mental Illness, "It is customary to define psychiatry as a medical specialty concerned with the study, diagnosis and treatment of mental illnesses. This is a worthless and misleading definition. Mental illness is a myth...
...respected researcher who was one of the first to use cyclosporine may have found a better way to make transplants succeed. Dr. Thomas Starzl of the University of Pittsburgh, the world's largest transplant center, is expected to report in the British journal Lancet this week that a new drug, FK-506, is proving to be more powerful and less toxic than cyclosporine. In more than 100 patients taking FK-506 for up to eight months, the rate of organ rejection was only one-sixth as high as in those using cyclosporine. Side effects were minimal, though long-term consequences...